Literature DB >> 23907326

SPECT/CT sentinel lymph node identification in papillary thyroid cancer: lymphatic staging and surgical management improvement.

Amparo Garcia-Burillo1, Isabel Roca Bielsa, Oscar Gonzalez, Carles Zafon, Monica Sabate, Josep Castellvi, Xavier Serres, Carmela Iglesias, Ramon Vilallonga, Enric Caubet, Jose Manuel Fort, Jordi Mesa, Manuel Armengol, Joan Castell-Conesa.   

Abstract

PURPOSE: Lymphadenectomy in papillary thyroid carcinoma (PTC) continues to be controversial. A better staging method is needed to provide adequate individual surgical treatment. SPECT/CT lymphoscintigraphy and sentinel lymph node (SLN) biopsy may improve lymphatic staging and surgical treatment. Our main objectives were to describe the lymphatic drainage of PTC using lymphoscintigraphy, to evaluate the lymphatic spread (comparing SLN and lymphadenectomy results) and to analyse the impact of SLN identification in surgery.
METHODS: We prospectively studied 24 consecutive patients with PTC (19 women; mean age 52.7 years, range 22-81 years). The day before surgery, lymphoscintigraphy with ultrasound-guided intratumoral injection ((99m)Tc-nanocolloid, 148 MBq) was performed, obtaining planar and SPECT/CT images. All patients underwent total thyroidectomy, SLN biopsy (hand-held gamma probe) with perioperative analysis, central compartment node dissection, or laterocervical lymphadenectomy if perioperative stage N1b or positive SLNs in this lymphatic basin.
RESULTS: Lymphoscintigraphy revealed at least one SLN in 19 of 24 patients (79 %) on planar and SPECT/CT images, and in 23 of 24 patients (96 %) during surgery using a hand-held gamma probe. Lymph node metastases were detected with classical perioperative techniques (ultrasound guidance and surgical inspection) in 3 of 24 patients, by perioperative SLN analysis in 10 of 23, and by definitive histology in 13 of 24. The false-negative (FN) ratio for SLN was 7.7 % (one patient with bulky lymph nodes). The FN ratio for perioperative frozen sections was 15.4 % (two patients, one with micrometastases, the other with bilateral SLN). Lymphatic drainage was only to the central compartment in 6 of 24 patients (3 of the 6 with positive SLNs for metastases), only to the laterocervical basin in 5 of 24 patients (all unilateral, 2 of 5 positive SLNs) and to the central and laterocervical compartments in 12 of 24 patients (6 of 12 and 3 of 12 positive SLNs, respectively).
CONCLUSION: Lymphoscintigraphy reveals the lymph node drainage in a high proportion of patients. It detects laterocervical drainage in a significant percentage of patients, allowing the detection of occult lymph node metastases and improving the surgical management in PTC.

Entities:  

Mesh:

Year:  2013        PMID: 23907326     DOI: 10.1007/s00259-013-2476-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  52 in total

1.  Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.

Authors:  Catharina Ihre Lundgren; Per Hall; Paul W Dickman; Jan Zedenius
Journal:  Cancer       Date:  2006-02-01       Impact factor: 6.860

2.  Systematic review and meta-analysis of sentinel node biopsy in thyroid cancer.

Authors:  S P Balasubramanian; B J Harrison
Journal:  Br J Surg       Date:  2011-01-18       Impact factor: 6.939

3.  Detecting the sentinel lymph node in patients with differentiated thyroid carcinoma.

Authors:  L Rettenbacher; P Sungler; D Gmeiner; H Kässmann; G Galvan
Journal:  Eur J Nucl Med       Date:  2000-09

4.  The efficacy of lateral neck sentinel lymph node biopsy in papillary thyroid carcinoma.

Authors:  Se Kyung Lee; Sung Hoon Kim; Sung Mo Hur; Jun-Ho Choe; Jung-Han Kim; Jee Soo Kim
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

5.  Sentinel lymph node (SLN) procedure with patent V blue dye in 153 patients with papillary thyroid carcinoma (PTC): is it an accurate staging method?

Authors:  D Rubello; C Nanni; I Merante Boschin; A Toniato; A Piotto; L Rampin; G Mariani; A Al-Nahhas; M R Pelizzo
Journal:  J Exp Clin Cancer Res       Date:  2006-12

6.  Sentinel lymph node biopsy in thyroid tumors: a pilot study.

Authors:  Sandro J Stoeckli; Madeleine Pfaltz; Hans Steinert; Stephan Schmid
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-03-18       Impact factor: 2.503

7.  Sentinel lymph node biopsy in papillary thyroid cancer: comparison study of blue dye method and combined radioisotope and blue dye method in papillary thyroid cancer.

Authors:  S K Lee; J H Choi; H I Lim; W W Kim; S M Kim; J H Choe; J E Lee; J H Shin; J Y Choi; J H Kim; J S Kim; S J Nam; J H Yang
Journal:  Eur J Surg Oncol       Date:  2009-03-13       Impact factor: 4.424

Review 8.  Surgical approaches in thyroid cancer and lymph-node metastases.

Authors:  Henning Dralle; Andreas Machens
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2008-12       Impact factor: 4.690

9.  [Identification of sentinel lymph nodes in thyroid carcinoma].

Authors:  R Dzodic; I Marković; M Inić; N Jokić; M Zegarac; I Djuricic; Z Milovanović; G Pupic; N Jovanović
Journal:  Acta Chir Iugosl       Date:  2003

10.  Detection of sentinel lymph nodes in patients with papillary thyroid cancer.

Authors:  Hiroshi Takami; Kazuyoshi Sasaki; Yoshifumi Ikeda; Gengo Tajima; Kaori Kameyama
Journal:  Asian J Surg       Date:  2003-07       Impact factor: 2.767

View more
  6 in total

1.  Radioguided sentinel lymph node biopsy in patients with papillary thyroid carcinoma.

Authors:  Mattia Portinari; Paolo Carcoforo
Journal:  Gland Surg       Date:  2016-12

2.  Synthesis of the first radiolabeled 188Re N-heterocyclic carbene complex and initial studies on its potential use in radiopharmaceutical applications.

Authors:  Thomas Wagner; Brian M Zeglis; Sam Groveman; Claudia Hille; Alexander Pöthig; Lynn C Francesconi; Wolfgang A Herrmann; Fritz E Kühn; Thomas Reiner
Journal:  J Labelled Comp Radiopharm       Date:  2014-05-29       Impact factor: 1.921

3.  Value of sentinel lymph node biopsy in papillary thyroid cancer: initial results of a prospective trial.

Authors:  R N Cabrera; C T Chone; D Zantut-Wittmann; P Matos; D M Ferreira; P S G Pereira; R J R Ferrari; A O Santos; A N Crespo; E C S C Etchebehere
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-03       Impact factor: 2.503

Review 4.  Sentinel lymph node biopsy in small papillary thyroid cancer. A review on novel surgical techniques.

Authors:  Ludovico Maria Garau; Domenico Rubello; Alice Ferretti; Giuseppe Boni; Duccio Volterrani; Gianpiero Manca
Journal:  Endocrine       Date:  2018-07-02       Impact factor: 3.633

5.  One-step nucleic acid amplification analysis of sentinel lymph nodes in papillary thyroid cancer patients.

Authors:  Krzysztof A Kaczka; Lech Pomorski
Journal:  Arch Med Sci       Date:  2017-01-25       Impact factor: 3.318

6.  The Diagnostic Accuracy of One-Step Nucleic Acid Amplification for Lymph Node Metastases of Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Xiaofei Wang; Xun Zheng; Jingqiang Zhu; Zhihui Li; Tao Wei
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-04       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.